Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 2, 2019
The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluations
Samron Brhane Gebregergish, Mahmoud Hashim, Bart Heeg, et al.
Journal of Medical Economics
|
January 7, 2020
Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of <i>RAS</i> wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study
Sebastian Stintzing, Ilse van Oostrum, Chris P Pescott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013
Mata Charokopou, Istvan M Majer, Johan de Raad, et al.
Research Synthesis Methods
|
October 25, 2022
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses
Ofir Harari, Mohsen Soltanifar, Joseph C Cappelleri, et al.
Future Oncology (London, England)
|
April 16, 2021
Comparing cure rates for gemtuzumab ozogamicin plus standard chemotherapy vs standard chemotherapy alone in acute myeloid leukemia patients
Bogdan Muresan, Carla Mamolo, Joseph C Cappelleri, et al.
Journal of Comparative Effectiveness Research
|
January 18, 2023
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity
Bart Heeg, Andre Verhoek, Gabriel Tremblay, et al.
Clinical Lung Cancer
|
July 14, 2023
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes
Julien Mazieres, Helene Vioix, Boris M Pfeiffer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs
Ilse van Oostrum, Mario Ouwens, Antonio Remiro-Azócar, et al.
Future Oncology (London, England)
|
February 24, 2022
Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review
T Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2008
The cost-effectiveness of atypicals in the UK
Bart Heeg, Erik Buskens, Marc Botteman, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 2, 2019
The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluations
Samron Brhane Gebregergish, Mahmoud Hashim, Bart Heeg, et al.
Journal of Medical Economics
|
January 7, 2020
Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of <i>RAS</i> wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study
Sebastian Stintzing, Ilse van Oostrum, Chris P Pescott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013
Mata Charokopou, Istvan M Majer, Johan de Raad, et al.
Research Synthesis Methods
|
October 25, 2022
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses
Ofir Harari, Mohsen Soltanifar, Joseph C Cappelleri, et al.
Future Oncology (London, England)
|
April 16, 2021
Comparing cure rates for gemtuzumab ozogamicin plus standard chemotherapy vs standard chemotherapy alone in acute myeloid leukemia patients
Bogdan Muresan, Carla Mamolo, Joseph C Cappelleri, et al.
Journal of Comparative Effectiveness Research
|
January 18, 2023
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity
Bart Heeg, Andre Verhoek, Gabriel Tremblay, et al.
Clinical Lung Cancer
|
July 14, 2023
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes
Julien Mazieres, Helene Vioix, Boris M Pfeiffer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs
Ilse van Oostrum, Mario Ouwens, Antonio Remiro-Azócar, et al.
Future Oncology (London, England)
|
February 24, 2022
Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review
T Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2008
The cost-effectiveness of atypicals in the UK
Bart Heeg, Erik Buskens, Marc Botteman, et al.
Page
of 5